section name header

Indications ⬇

High Alert


Unlabeled Use:
  • Ovarian cancer that has progressed despite treatment with other agents.

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Adverse reactions are noted for the combination of oxaliplatin, 5-fluorouracil and leucovorin

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

Renal Impairment

US Brand Names ⬆ ⬇

Eloxatin

Action ⬆ ⬇

  • Inhibits DNA replication and transcription by incorporating platinum into normal cross-linking (cell-cycle nonspecific).
Therapeutic effects:
  • Death of rapidly replicating cells, particularly malignant ones.

Classifications ⬆ ⬇

Therapeutic Classification: antineoplastics

Pharmacologic Classification: alkylating agents

Pharmacokinetics ⬆ ⬇

Absorption: IV administration results in complete bioavailability.

Distribution: Extensive tissue distribution.

Protein Binding: >90% (platinum).

Metabolism/Excretion: Undergoes rapid and extensive nonenzymatic biotransformation; excreted mostly by the kidneys.

Half-Life: 391 hrs.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
IVunknownunknownunknown

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

ox-A-li-pla-tin

Code ⬆

NDC Code